InvestorsHub Logo

olden_grumpini

01/11/21 1:50 PM

#339355 RE: Jhawker #339354

Thanks for article. Where's Leo?

“We’re probably not even through the first inning of what we’re going to learn here,” said Wendy Holman, CEO of Ridgeback Biotherapeutics, which is working with Merck & Co. on an antiviral drug against COVID-19. Holman spoke during a Fierce JPM Week panel on COVID-19 therapeutics Monday.


I posted this morning that the Ridgeback/Merck therapeutic is one to keep an eye on. IPIX better put on their cleats and take the field if they want to be in this game.

TheDane

01/11/21 2:20 PM

#339358 RE: Jhawker #339354

Thanks. I just sent the writer an email with links to IPIX press releases.

Go Leo!